Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FHJHP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,900
Award facts
- Contract value 100% obligated
- $2,900.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,900.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen auto-injectors on September 26, 2025, with completion scheduled for September 29, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary distribution hub for federal medical procurement.
This delivery order is one of numerous pharmaceutical supply contracts through which AmerisourceBergen supports the Defense Health Agency and U.S. military healthcare systems. Trulicity, a diabetes management medication, represents the type of specialty pharmaceutical products supplied under the broader IDC vehicle, which encompasses brand-name and generic drugs, vaccines, medical devices, and other healthcare commodities across multiple therapeutic domains. The SPE2DX contract serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to fulfill medical supply needs for military healthcare programs worldwide, with the DLA planning to establish additional regional Pharmaceutical Prime Vendor Global Program Generation V contracts in the future.
Quick answers
Who was awarded contract SPE2DB25FHJHP?
SPE2DB25FHJHP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FHJHP worth?
The government has obligated $2,900 on SPE2DB25FHJHP.
Is contract SPE2DB25FHJHP an order under another contract?
Yes. SPE2DB25FHJHP is a delivery order under SPE2DB24D2208, an indefinite delivery contract.
Was contract SPE2DB25FHJHP competed?
The extent of competition for SPE2DB25FHJHP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award